Literature DB >> 9679867

Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer.

J A Wieder1, M S Soloway.   

Abstract

PURPOSE: During radical prostatectomy for prostate cancer tumor at the surgical margin is a relatively frequent finding. We summarize the literature on the incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy.
MATERIALS AND METHODS: The literature was reviewed for data on positive margins during radical prostatectomy for prostate cancer.
RESULTS: Positive surgical margins may result from artifacts induced by tissue processing, incising inadvertently into the prostate or incising into extraprostatic tumor that has extended beyond the limits of resection. Patients with 10 ng./ml. or greater preoperative prostate specific antigen, biopsy Gleason score 7, multiple positive biopsies, or clinical stage T2b, T2c or T3 cancer have a higher risk of positive margins. Preoperative endorectal magnetic resonance imaging may be useful in staging a select group of patients. Neoadjuvant androgen deprivation reduces the incidence of positive margins but does not appear to delay progression or improve survival. The surgical approach, retropubic or perineal, may influence the location and etiology of positive margins. In general, nerve and bladder neck sparing procedures do not compromise tumor removal in appropriately selected patients. Positive margins increase the risk of progression and correlate with decreased cancer specific and overall survival. There is no consensus on the management of positive margins. External beam radiation and androgen deprivation may be administered as adjuvant therapy or at the time of recurrence.
CONCLUSIONS: Tumor at the specimen edge is an adverse prognostic factor. With appropriate patient selection and meticulous surgical technique some positive margins can be prevented. Controlled prospective randomized studies of postoperative therapy are needed before definitive recommendations can be made for treating positive margins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9679867

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  64 in total

Review 1.  Laparoscopic radical prostatectomy: published series.

Authors:  András Hoznek; David B Samadi; Laurent Salomon; Alexandre De La Taille; Leif E Olsson; Clément-Claude Abbou
Journal:  Curr Urol Rep       Date:  2002-04       Impact factor: 3.092

2.  Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy.

Authors:  Andrew J Stephenson; Alex Smith; Michael W Kattan; Jaya Satagopan; Victor E Reuter; Peter T Scardino; William L Gerald
Journal:  Cancer       Date:  2005-07-15       Impact factor: 6.860

3.  Magnetic resonance spectroscopy in patients with locally confined prostate cancer: association of prostatic citrate and metabolic atrophy with time on hormone deprivation therapy, PSA level, and biopsy Gleason score.

Authors:  Ullrich G Mueller-Lisse; Mark G Swanson; Daniel B Vigneron; John Kurhanewicz
Journal:  Eur Radiol       Date:  2006-06-22       Impact factor: 5.315

Review 4.  Prostate cancer treatment. The case for radical prostatectomy.

Authors:  Miles A Goldstraw
Journal:  Ann R Coll Surg Engl       Date:  2006-09       Impact factor: 1.891

5.  Endoscopic extraperitoneal radical prostatectomy: the University of Leipzig experience of 1,300 cases.

Authors:  Jens-Uwe Stolzenburg; Robert Rabenalt; Minh Do; Michael C Truss; Martin Burchardt; Thomas R Herrmann; Thilo Schwalenberg; Panagiotis Kallidonis; Evangelos N Liatsikos
Journal:  World J Urol       Date:  2007-03-02       Impact factor: 4.226

Review 6.  Oncological and functional results of open, robot-assisted and laparoscopic radical prostatectomy: does surgical approach and surgical experience matter?

Authors:  T R Herrmann; R Rabenalt; J U Stolzenburg; E N Liatsikos; F Imkamp; H Tezval; A J Gross; U Jonas; M Burchardt
Journal:  World J Urol       Date:  2007-03-13       Impact factor: 4.226

7.  Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice.

Authors:  Samantha J Hauff; Sharat C Raju; Ryan K Orosco; Andrew M Gross; Julio A Diaz-Perez; Elamprakash Savariar; Nadia Nashi; Jonathan Hasselman; Michael Whitney; Jeffrey N Myers; Scott M Lippman; Roger Y Tsien; Trey Ideker; Quyen T Nguyen
Journal:  Otolaryngol Head Neck Surg       Date:  2014-08-04       Impact factor: 3.497

8.  Role of endorectal coil magnetic resonance imaging in treatment of patients with prostate cancer and in determining radical prostatectomy surgical margin status: report of a single surgeon's practice.

Authors:  Jian Qing Zhang; Kevin R Loughlin; Kelly H Zou; Steven Haker; Clare M C Tempany
Journal:  Urology       Date:  2007-06       Impact factor: 2.649

9.  Robot-assisted laparoscopic radical prostatectomy: initial experience with first 112 cases.

Authors:  Ali Ihsan Tasci; Alper Bitkin; Yusuf Ozlem Ilbey; Volkan Tugcu; Erkan Sonmezay
Journal:  J Robot Surg       Date:  2011-09-04

10.  Scatter spectroscopic imaging distinguishes between breast pathologies in tissues relevant to surgical margin assessment.

Authors:  Ashley M Laughney; Venkataramanan Krishnaswamy; Elizabeth J Rizzo; Mary C Schwab; Richard J Barth; Brian W Pogue; Keith D Paulsen; Wendy A Wells
Journal:  Clin Cancer Res       Date:  2012-08-20       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.